Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2019 Results - Earnings Call Transcript [Seeking Alpha]
Amphastar Pharmaceuticals, Inc. (AMPH)
Last amphastar pharmaceuticals, inc. earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.amphastar.com/investor-relations
Company Research
Source: Seeking Alpha
Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2019 Results - Earnings Call Transcript Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH Company Participants Jason Shandell - President, General Counsel and Director William Peters - Chief Financial Officer, Treasurer and Senior Vice President of Finance Conference Call Participants David Maris - Wells Fargo Securities, LLC Gary Nachman - BMO Capital Markets David Amsellem - Piper Jaffray Companies Young Lee - Raymond James & Associates, Inc. David Steinberg - Jefferies LLC Gregory Gilbert - SunTrust Robinson Humphrey, Inc. Chad Messer - Needham & Company, LLC Operator Good day, ladies and gentlemen, and welcome to Amphastar first quarter earnings conference call. [Operator Instructions] All statements on this conference call that are not historical are forward-looking statements, including, among other things, statements relating to the company's expectation regarding future financial performance, backlog, sales and marketing of its product, ma
Show less
Read more
Impact Snapshot
Event Time:
AMPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMPH alerts
High impacting Amphastar Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
AMPH
News
- Unpacking Q3 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) In The Context Of Other Generic Pharmaceuticals Stocks [Yahoo! Finance]Yahoo! Finance
- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating. They now have a $36.00 price target on the stock, down previously from $66.00.MarketBeat
- Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceAccesswire
- Should You Be Adding Amphastar Pharmaceuticals (NASDAQ:AMPH) To Your Watchlist Today? [Yahoo! Finance]Yahoo! Finance
- Implied Volatility Surging for Amphastar Pharmceuticals (AMPH) Stock Options [Yahoo! Finance]Yahoo! Finance
AMPH
Earnings
- 11/6/24 - Beat
AMPH
Sec Filings
- 2/7/25 - Form SCHEDULE
- 12/16/24 - Form 4
- 12/11/24 - Form 4
- AMPH's page on the SEC website